Trending
Seafarers issue of ‘utmost importance’: Modi to TrumpWilliam (Bill) CoughlanDeath Notice of Marian O’Toole (Oughterard, Galway)IceCure Announces Pricing of $5.5 Million Private Placement Priced At a Premium to the Market Price with a Single Healthcare Focused Institutional InvestorDSC® Expands Advanced Manufacturing Capabilities in Indonesia to Strengthen its Global Ready StrategyWindsor House of Cars Begins Exclusive Delivery of the Fastest Supercar in the WorldPackTowl unveils spring 2027 Artist Series collection printsVivo X Fold 6 RAM, storage variants, color options revealed before launchMazda Argued Against Touchscreens for Years, Now Says They’re SaferCase against man accused of assaulting drag queen in Cork city adjourned5 Canadian Websites Ghanaians Can Use to Import CarsEAGC Exchange: Uganda, Kenya Grain Traders Move to Boost Regional TradeCourt dismisses petition seeking to stop EABL-Diageo shares dealFTSE 100 Live: London stocks edge higher, SpaceX wobbles ahead of Fed decisionDisney Unlocking 'The Simpsons' for Fortnite Games DevelopersSeafarers issue of ‘utmost importance’: Modi to TrumpWilliam (Bill) CoughlanDeath Notice of Marian O’Toole (Oughterard, Galway)IceCure Announces Pricing of $5.5 Million Private Placement Priced At a Premium to the Market Price with a Single Healthcare Focused Institutional InvestorDSC® Expands Advanced Manufacturing Capabilities in Indonesia to Strengthen its Global Ready StrategyWindsor House of Cars Begins Exclusive Delivery of the Fastest Supercar in the WorldPackTowl unveils spring 2027 Artist Series collection printsVivo X Fold 6 RAM, storage variants, color options revealed before launchMazda Argued Against Touchscreens for Years, Now Says They’re SaferCase against man accused of assaulting drag queen in Cork city adjourned5 Canadian Websites Ghanaians Can Use to Import CarsEAGC Exchange: Uganda, Kenya Grain Traders Move to Boost Regional TradeCourt dismisses petition seeking to stop EABL-Diageo shares dealFTSE 100 Live: London stocks edge higher, SpaceX wobbles ahead of Fed decisionDisney Unlocking 'The Simpsons' for Fortnite Games Developers

IceCure Announces Pricing of $5.5 Million Private Placement Priced At a Premium to the Market Price with a Single Healthcare Focused Institutional Investor

/PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology......

News Desk

Staff Writer

Published

Jun 18, 2026

Source

PR Newswire

Analytics

0 0 0
IceCure Announces Pricing of $5.5 Million Private Placement Priced At a Premium to the Market Price with a Single Healthcare Focused Institutional Investor

AI Insight:This news matters because it highlights IceCure's ability to secure funding at a premium, a crucial milestone for a medical technology company.

IceCure Medical Ltd., a developer of minimally-invasive cryoablation technology, has announced the pricing of a $5.5 million private placement with a single healthcare-focused institutional investor. The placement was priced at a premium to the market price, indicating strong demand for IceCure's technology. This strategic investment will likely support the company's continued growth and development of its cryoablation solutions, which are designed to provide minimally-invasive treatment options for various medical conditions. As a leading player in the medical technology sector, IceCure's ability to secure funding at a premium underscores its potential for long-term success and its commitment to advancing innovative healthcare solutions.